Does TAMOXIFEN Cause Tumour marker increased? 106 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 106 reports of Tumour marker increased have been filed in association with TAMOXIFEN (Tamoxifen Citrate). This represents 1.2% of all adverse event reports for TAMOXIFEN.
106
Reports of Tumour marker increased with TAMOXIFEN
1.2%
of all TAMOXIFEN reports
18
Deaths
8
Hospitalizations
How Dangerous Is Tumour marker increased From TAMOXIFEN?
Of the 106 reports, 18 (17.0%) resulted in death, 8 (7.5%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAMOXIFEN. However, 106 reports have been filed with the FAERS database.
What Other Side Effects Does TAMOXIFEN Cause?
Malignant neoplasm progression (1,499)
Metastases to bone (894)
Fatigue (729)
Nausea (611)
Metastases to liver (595)
Breast cancer (584)
Disease progression (571)
Breast cancer metastatic (515)
Diarrhoea (512)
Arthralgia (497)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which TAMOXIFEN Alternatives Have Lower Tumour marker increased Risk?
TAMOXIFEN vs TAMSULOSIN
TAMOXIFEN vs TAPENTADOL
TAMOXIFEN vs TAPINAROF
TAMOXIFEN vs TARCEVA
TAMOXIFEN vs TARLATAMAB